Marianne P. Allen

Array ( [id] => 9865287 [patent_doc_number] => 20150045307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'IDENTIFICATION OF A NOVEL BHD GENE' [patent_app_type] => utility [patent_app_number] => 14/519377 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29646 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14519377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10219421 [patent_doc_number] => 20150104414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/518705 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21456 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10219501 [patent_doc_number] => 20150104494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'METHODS FOR REPAIR OF EAR CANAL TISSUE DEFECTS' [patent_app_type] => utility [patent_app_number] => 14/514309 [patent_app_country] => US [patent_app_date] => 2014-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9483 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14514309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10290676 [patent_doc_number] => 20150175676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'Fusion Polypeptides Capable Of Activating Receptors' [patent_app_type] => utility [patent_app_number] => 14/511786 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15394 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408976 [patent_doc_number] => 09556268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Therapeutic agent' [patent_app_type] => utility [patent_app_number] => 14/511099 [patent_app_country] => US [patent_app_date] => 2014-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 39 [patent_no_of_words] => 20760 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10214709 [patent_doc_number] => 20150099701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-09 [patent_title] => 'MODIFIED ACIDIC FIBROBLAST GROWTH FACTORS AND COMPOSITION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/508118 [patent_app_country] => US [patent_app_date] => 2014-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3812 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14508118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11074301 [patent_doc_number] => 20160271265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'INSULIN-LIKE GROWTH FACTOR MIMETICS FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 15/026792 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19412 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17058971 [patent_doc_number] => 11103553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-31 [patent_title] => Modified fibroblast growth factors for the treatment of ocular disorders [patent_app_type] => utility [patent_app_number] => 15/024824 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 20507 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684438 [patent_doc_number] => 20160030584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'METHOD FOR PRESERVING AND STABILISING PROTEINS, WHICH CAN BE USED FOR INDUSTRIAL DEVELOPMENT OF FORMULATIONS OF SANITARY, PHARMACEUTICAL AND COSMETIC PRODUCTS' [patent_app_type] => utility [patent_app_number] => 14/759320 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1613 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10240462 [patent_doc_number] => 20150125455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/486050 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 49200 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932113 [patent_doc_number] => 20150080304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'TREATMENT AND PREVENTION OF RADIATION INJURY USING MFG-E8' [patent_app_type] => utility [patent_app_number] => 14/481959 [patent_app_country] => US [patent_app_date] => 2014-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9909 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325760 [patent_doc_number] => 20150210765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'Multivalent and Monovalent Multispecific Complexes and Their Uses' [patent_app_type] => utility [patent_app_number] => 14/481181 [patent_app_country] => US [patent_app_date] => 2014-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 107348 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208390 [patent_doc_number] => 20150093377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis' [patent_app_type] => utility [patent_app_number] => 14/476802 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 91051 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14476802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838940 [patent_doc_number] => 20150031020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'ENZYME-PORE CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 14/455394 [patent_app_country] => US [patent_app_date] => 2014-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30494 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14455394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968204 [patent_doc_number] => 20140371237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth' [patent_app_type] => utility [patent_app_number] => 14/453090 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19552 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14453090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901011 [patent_doc_number] => 20150056211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins' [patent_app_type] => utility [patent_app_number] => 14/444912 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 233 [patent_figures_cnt] => 233 [patent_no_of_words] => 53375 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901011 [patent_doc_number] => 20150056211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins' [patent_app_type] => utility [patent_app_number] => 14/444912 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 233 [patent_figures_cnt] => 233 [patent_no_of_words] => 53375 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11596850 [patent_doc_number] => 09644002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-09 [patent_title] => 'Allosteric modulators of EGFR and constitutively active mutants' [patent_app_type] => utility [patent_app_number] => 14/341529 [patent_app_country] => US [patent_app_date] => 2014-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20542 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14341529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10946902 [patent_doc_number] => 20140349924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Stable Non-Aqueous Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 14/336562 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18504 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805222 [patent_doc_number] => 20150017166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'REGULATION OF GLUCOSE METABOLISM USING ANTI-CGRP ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/323028 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 45413 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323028 [rel_patent_id] =>[rel_patent_doc_number] =>)